University of Michigan - Ann Arbor

An international cohort study was conducted to investigate the mortality and pulmonary complications in patients who underwent surgery while having a perioperative SARS-CoV-2 (COVID-19) infection.

International Cohort Study on COVID-19 Patient Mortality Following Surgery

Nepogodiev D, Glasbey J, Li E et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet. 2020. doi:10.1016/s0140-6736(20)31182-x

https://www.sciencedirect.com/science/article/pii/S014067362031182X?via%3Dihub

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

- Overall, the 30-day mortality rate of the 1,128 patients diagnosed with a COVID-19 infection that had undergone surgery was estimated to be 23.8% (n=268).

30-day Morality Rate of COVID-19 Patients Undergoing Surgery

- Pulmonary complications were predictive of 30-day mortality. 51.2% of patients experienced pulmonary complications is was significantly higher than the estimated baseline of 10% prior to the pandemic.

- 30-day mortality was also significantly greater in those experiencing pulmonary complications than those that didn’t not experience complications at 38.0% and 8.7%, respectively. 

- 30-day morality of those experiencing acute distress syndrome, pneumonia, or unexpected postoperative ventilation were 63.0%, 37.9%, and 41.7%, respectively. 

Learn Before

Related